267 related articles for article (PubMed ID: 37475161)
1. Rutin is a potent senomorphic agent to target senescent cells and can improve chemotherapeutic efficacy.
Liu H; Xu Q; Wufuer H; Li Z; Sun R; Jiang Z; Dou X; Fu Q; Campisi J; Sun Y
Aging Cell; 2024 Jan; 23(1):e13921. PubMed ID: 37475161
[TBL] [Abstract][Full Text] [Related]
2. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria-targeted senotherapeutic interventions.
Atayik MC; Çakatay U
Biogerontology; 2022 Aug; 23(4):401-423. PubMed ID: 35781579
[TBL] [Abstract][Full Text] [Related]
4. Cellular senescence in bone.
Farr JN; Khosla S
Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
[TBL] [Abstract][Full Text] [Related]
5. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy.
Özdemir A; Şimay Demir YD; Yeşilyurt ZE; Ark M
Adv Protein Chem Struct Biol; 2023; 133():115-158. PubMed ID: 36707199
[TBL] [Abstract][Full Text] [Related]
6. Senotherapeutics for mesenchymal stem cell senescence and rejuvenation.
Wong PF; Dharmani M; Ramasamy TS
Drug Discov Today; 2023 Jan; 28(1):103424. PubMed ID: 36332835
[TBL] [Abstract][Full Text] [Related]
7. The implication of ROCK 2 as a potential senotherapeutic target via the suppression of the harmful effects of the SASP: Do senescent cancer cells really engulf the other cells?
Şimay Demir YD; Özdemir A; Sucularlı C; Benhür E; Ark M
Cell Signal; 2021 Aug; 84():110007. PubMed ID: 33845155
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of senescent cell secretomes to identify common and specific features of the different senescent phenotypes: a tool for developing new senotherapeutics.
Oguma Y; Alessio N; Aprile D; Dezawa M; Peluso G; Di Bernardo G; Galderisi U
Cell Commun Signal; 2023 Sep; 21(1):262. PubMed ID: 37770897
[TBL] [Abstract][Full Text] [Related]
9. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
Lagoumtzi SM; Chondrogianni N
Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
[TBL] [Abstract][Full Text] [Related]
10. Targeting Cellular Senescence with Senotherapeutics: Development of New Approaches for Skin Care.
Thompson EL; Pitcher LE; Niedernhofer LJ; Robbins PD
Plast Reconstr Surg; 2022 Oct; 150():12S-19S. PubMed ID: 36170431
[TBL] [Abstract][Full Text] [Related]
11. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies.
Khalil R; Diab-Assaf M; Lemaitre JM
Cells; 2023 Mar; 12(6):. PubMed ID: 36980256
[TBL] [Abstract][Full Text] [Related]
12. Senotherapeutics to Counteract Senescent Cells Are Prominent Topics in the Context of Anti-Ageing Strategies.
Calabrò A; Accardi G; Aiello A; Caruso C; Galimberti D; Candore G
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339070
[TBL] [Abstract][Full Text] [Related]
13. Translating Senotherapeutic Interventions into the Clinic with Emerging Proteomic Technologies.
Dey AK; Banarjee R; Boroumand M; Rutherford DV; Strassheim Q; Nyunt T; Olinger B; Basisty N
Biology (Basel); 2023 Oct; 12(10):. PubMed ID: 37887011
[TBL] [Abstract][Full Text] [Related]
14. Targeting Senescent Cells in Fibrosis: Pathology, Paradox, and Practical Considerations.
Schafer MJ; Haak AJ; Tschumperlin DJ; LeBrasseur NK
Curr Rheumatol Rep; 2018 Jan; 20(1):3. PubMed ID: 29374361
[TBL] [Abstract][Full Text] [Related]
15. Senolytic and senomorphic interventions to defy senescence-associated mitochondrial dysfunction.
Nehlin JO
Adv Protein Chem Struct Biol; 2023; 136():217-247. PubMed ID: 37437979
[TBL] [Abstract][Full Text] [Related]
16. Aging and oral squamous cell carcinoma development: the role of cellular senescence.
Niklander SE; Aránguiz P; Faunes F; Martínez-Flores R
Front Oral Health; 2023; 4():1285276. PubMed ID: 37904749
[TBL] [Abstract][Full Text] [Related]
17.
Woo J; Shin S; Ji H; Ryu D; Cho E; Kim Y; Kim J; Park D; Jung E
Nutrients; 2022 May; 14(9):. PubMed ID: 35565945
[TBL] [Abstract][Full Text] [Related]
18. Plant-Derived Senotherapeutics for the Prevention and Treatment of Intervertebral Disc Degeneration and Aging.
Mavrogonatou E; Kletsas D
Metabolites; 2024 Feb; 14(3):. PubMed ID: 38535306
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapeutic approach to reduce senescent cells and alleviate senescence-associated secretory phenotype in mice.
Shrestha N; Chaturvedi P; Zhu X; Dee MJ; George V; Janney C; Egan JO; Liu B; Foster M; Marsala L; Wong P; Cubitt CC; Foltz JA; Tran J; Schappe T; Hsiao K; Leclerc GM; You L; Echeverri C; Spanoudis C; Carvalho A; Kanakaraj L; Gilkes C; Encalada N; Kong L; Wang M; Fang B; Wang Z; Jiao JA; Muniz GJ; Jeng EK; Valdivieso N; Li L; Deth R; Berrien-Elliott MM; Fehniger TA; Rhode PR; Wong HC
Aging Cell; 2023 May; 22(5):e13806. PubMed ID: 36967480
[TBL] [Abstract][Full Text] [Related]
20. Exploring the fuzzy border between senolytics and senomorphics with chemoinformatics and systems pharmacology.
Olascoaga-Del Angel KS; Gutierrez H; Königsberg M; Pérez-Villanueva J; López-Diazguerrero NE
Biogerontology; 2022 Aug; 23(4):453-471. PubMed ID: 35781578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
